Navigation Links
One-Third of Patients Discontinue Common Breast Cancer Therapy

PRINCETON, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarming study that appeared in the March 1, 2007 issue of CANCER (a peer-reviewed journal of the American Cancer Society), reports that one-third of women taking the standard five-year regimen of the hormonal breast cancer treatment tamoxifen citrate, discontinue therapy early.(1)

According to the authors, non-compliance with tamoxifen tablets is a major issue that may negatively affect treatment efficacy. While tamoxifen tablets remain a standard of care, according to these data, they are associated with compliance and persistency issues. Oncologists need to identify those at risk of non-persistence and develop strategies to combat this barrier to treatment success.

Patients at risk of non-persistence include those who prefer alternative delivery formats to traditional pills/tablets, such as liquid formulations. SOLTAMOX, the only liquid form of tamoxifen citrate, is an alternative for women who require tamoxifen therapy. SOLTAMOX may be an attractive option for women who do not like pills or cannot swallow pills. SOLTAMOX is approved by the FDA and is available in the U.S. through Cytogen Corporation. For more information about SOLTAMOX, please visit www.soltamoxus.com. -0-

WHO:   Linda Vahdat, MD, Weill Cornell Medical Center. Dr. Vahdat is a

        leading breast cancer expert and a participant in the

        Compliance Strategic Initiative -- a program designed to

        increase awareness compliance and to raise awareness

        importance of hormonal therapy in breast cancer.


WHAT:  Dr. Vahdat is available to speak with media regarding the

        importance of tamoxifen compliance and the need to offer

        patients more options.


WHEN:  March 2007


WHERE: Please contact Eliza Schleifstein (973) 387-0342 to set up a

        convenient time to interview Dr. Vahdat.

About SOLTAMOX

SOLTAMOX (tamoxifen c
'"/>




Page: 1 2 3

Related medicine technology :

1. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
2. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
3. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
6. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
9. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
10. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
11. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One Third Patients Discontinue Common Breast Cancer Therapy
(Date:12/24/2014)... PHILADELPHIA , Dec. 23, 2014 ... a medical device company focused on skin permeation, ... that Scott W. Hollander has been ... Mr. Hollander has more than 20 years of ... equipment industries, and most recently served as Vice ...
(Date:12/24/2014)... ResMed (NYSE: RMD ) today announced its victory ... manufacturer BMC Medical Co., Ltd. The International ... infringe ResMed,s patents, and entered an order prohibiting BMC from ... United States : , iVolve nasal mask ... pillows mask , iVolve full face mask ...
(Date:12/24/2014)... LEXINGTON, Mass. , Dec. 23, 2014 /PRNewswire/ ... GEVA ), a biopharmaceutical company developing therapeutic products ... European Medicines Agency (EMA) of the Marketing Authorization ... The EMA recently granted the company,s request for ... the EMA,s regulatory review time.   ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... Calif., Nov. 4, 2010 ThermoGenesis Corp. (Nasdaq: ... that process and store adult stem cells, said today that ... million, a 35 percent increase over revenues of $5.2 million ... a separate release today, the Company announced it has signed ...
... 2010 The Society for Biomolecular Sciences, now officially ... Automation and Screening (SLAS), invites students, graduate students, post-doctoral ... Academic Travel Award to be used for the SBS ... Orlando, FL, USA. Applicants must be the ...
Cached Medicine Technology:ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute 2ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute 3ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute 4ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute 5ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute 6ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute 7Applications Now Being Accepted for SBS 17th Annual Conference & Exhibition Academic Travel Awards 2
(Date:12/24/2014)... 2014 (HealthDay News) -- Adults who experienced childhood ... migraine headaches, suggests a study published online Dec. ... "Childhood maltreatment can have long-lasting effects, like associated ... study author Dawn Buse, director of behavioral medicine ... said in a journal news release. "When ...
(Date:12/24/2014)... December 24, 2014 Gluten, a protein ... those who have an intolerance to gluten, causing side ... bloating, migraine headaches, joint pain and fatigue. For this ... plans that deliver safe and fast weight loss ... trigger a gluten allergy reaction. These gluten free diet ...
(Date:12/24/2014)... NY (PRWEB) December 24, 2014 The ... with regards to the various market dynamics such as ... robot assisted arthroscopy, the wait time for U.S. sports ... sports medicine market, and the challenges faced by the ... http://www.researchmoz.us/global-sports-medicine-market-report-2014-edition-report.html , The report also provides an ...
(Date:12/24/2014)... “ Relax Melodies ” was featured ... features the latest and coolest mobile applications on the ... technology expert and host of NewsWatch, conducted the app ... users so they can fall asleep. , According to ... they have some sort of difficulty sleeping. Since that’s ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 In ... the United States rode bicycles, hand cycles and recumbent ... D.C. in the inaugural CanAm Veterans’ Challenge . ... non-profit World T.E.A.M. Sports about this inspiring ride, is ... more than 50 full color photographs taken during the ...
Breaking Medicine News(10 mins):Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3Health News:Sports Medicine Market Report 2014: Global Industry Analysis, Share, Size, Trends, Growth and Forecast report 2Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 3
... Gain MomentumCHICAGO, March 3 Accertify www.accertify.com ... prevention solutions to online merchants, today announced that ... a developer and marketer of scientifically formulated, premium ... blend of the Amazonian acai berry and 18 ...
... March 3 Clarient, Inc. (Nasdaq: ... testing services resource for pathologists, oncologists and the pharmaceutical ... Company has renewed, expanded and extended its senior subordinated ... (NYSE: SFE ), Clarient,s majority shareholder."In the ...
... and software testing firm for medical device makers ... Technical Report, QA Software Automation and Testing. ... software quality assurance project managers tools to analyze ... the right people to automate software quality assurance ...
... accepting entries for the 2009 HealthLeaders Media Marketing Awards Program through May ... in one of 22 categories. , ... Marblehead, MA (PRWEB) March 3, ... 2009 HealthLeaders Media Marketing Awards Program through May 29, 2009. Campaigns ...
... any room, The Flag Company, Inc.,s new ,Feel Good, Light Lenses ... spirits during this trying economical time. , ... (PRWEB) ... that has gripped the nation, the Flag Company, Inc. recently launched ...
... Women,s and Children,s Hospital (KKH) can now opt for a "non-contact" ... almost painless operation to treat uterine fibroids. , ... ... KK Women,s and Children,s Hospital (KKH) can now opt for ...
Cached Medicine News:Health News:MonaVie Chooses Accertify for Online Fraud Prevention 2Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 2Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 3Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 4Health News:For Medical Device Makers, Full Spectrum Software Releases New Software Technical Report, QA Software Automation and Software Testing 2Health News:Entry Period Opens for the 2009 HealthLeaders Media Marketing Awards Program with 11 New Categories 2Health News:Entry Period Opens for the 2009 HealthLeaders Media Marketing Awards Program with 11 New Categories 3Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 2Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: